产品
编 号：F496874
分子式：C30H39N5O7S2
分子量：645.79
分子式：C30H39N5O7S2
分子量：645.79
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
结构图
CAS No: 88373-73-3
产品详情
生物活性：
DPDPE, an opioid peptide, is a selective δ-opioid receptor?(DOR) agonist?with anticonvulsant effects.
体内研究：
DPDPE (70 or 140 nM; i.c.v.; once) shows anticonvulsant effects in rats.DPDPE (0.78–25 μg/mouse; i.c.v.; once) enhances bicuculline-induced convulsions in mouse.Animal Model:Male Sprague-Dawley rats (225-275 g)
Dosage:70 or 140 nM followed by a 2 μl saline flush
Administration:Intracerebroventricular injection
Result:Resulted in a significant, dose-dependent increase in the convulsive threshold to flurothyl.
Animal Model:Male ddY mice weighing 20–30 g, pretreated with 1.5 mg/kg bicuculline (subcutaneous injection).
Dosage:0.78–25 μg/mouse, once
Administration:Intracerebroventricular injection
Result:Caused a dose-dependent increase in the proportion of mice exhibiting convulsions.
DPDPE, an opioid peptide, is a selective δ-opioid receptor?(DOR) agonist?with anticonvulsant effects.
体内研究：
DPDPE (70 or 140 nM; i.c.v.; once) shows anticonvulsant effects in rats.DPDPE (0.78–25 μg/mouse; i.c.v.; once) enhances bicuculline-induced convulsions in mouse.Animal Model:Male Sprague-Dawley rats (225-275 g)
Dosage:70 or 140 nM followed by a 2 μl saline flush
Administration:Intracerebroventricular injection
Result:Resulted in a significant, dose-dependent increase in the convulsive threshold to flurothyl.
Animal Model:Male ddY mice weighing 20–30 g, pretreated with 1.5 mg/kg bicuculline (subcutaneous injection).
Dosage:0.78–25 μg/mouse, once
Administration:Intracerebroventricular injection
Result:Caused a dose-dependent increase in the proportion of mice exhibiting convulsions.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备